AstraZeneca Crestor Post-NDA Studies Focusing On 40 Mg Dose

AstraZeneca's ongoing trials of Crestor are focusing on 40 mg as the maximum dose of the cholesterol-lowering drug

More from Archive

More from Pink Sheet